Abstract:Primary signet ring cell (SRCC) of the lung is an extremely rare subtype of lung adenocarcinoma with a poor prognosis. Studies have shown a prevalence of distant metastases at initial diagnosis in lung SRCC. The role of palliative radiotherapy in lung SRRC with distant organ metastases needs to evolve. We analyzed SEER data to examine the role of palliative radiation in metastatic lung SRRC. Data were obtained from SEER database between 2010-2014.Patients of interest were identified by site recode C34.0-34.9 and ICD-O-3 code 8490/3 from SEER. We recorded metastatic information related to specific-organ metastases. Overall survival (OS) was calculated from the date of diagnosis using Kaplan Meier (KM) survival analysis and Cox regression model for comparisons of hazard ratio (HR) among subgroup. A two side p value <0.05 was regarded statistically significant. A total of 242 patients with metastatic lung SRCC were included. The median age was 64. 227 patients have a single-organ site of metastases while 15 patients have multi-organ metastases. For patients with single site metastases, the proportion of bone, brain, liver, lung metastasis was 41.0%, 20.7%, 12.8%, 25.6%, respectively. The mean survival was 10.3 months (95% CI=8.4-12.2), 1-yr OS ,2-yr OS was 28.50%, 14.40%, respectively. There was significant difference in OS between single site metastatic lung SRCC patients received palliative radiotherapy (yes vs no, Mean Survival (MS) 12.4 months vs 8.5 months) (p<0.001). For patients with isolated brain metastases at diagnosis, addition of palliative radiation improved OS significantly (MS 14.9 months; 1-yr OS 49.1%; 2-yr OS 18.9%;) compared to no radiation (MS 4.9 months, 1-yr OS 7.1%; log-rank p=0.005). OS was significantly different between patients with isolated-liver metastases treated with radiation (MS 11.3 months; 1-yr OS 36.4%; 2-yr OS 24.2%) versus no radiation (MS 7.5 months; 1-yr OS 18.8%; 2-yr OS 9.4%; log-rank p=0.04). For patients with isolated bone metastases , palliative radiation didn’t improve OS significantly (MS 9.9 months; 1-yr OS 24.7%; 2-yr OS 12.4%) compared to no radiation (MS 8.8 months; 1-yr OS 25.8%; 2-yr OS 8.2%; p=0.217). For isolated lung metastases patients underwent radiotherapy, MS was 12 months, 1-yr, 2-yr OS were 45.6%, 27.3%, which was significantly different versus no radiation (MS 3 months; 1-yr OS 22.5%; 2-yr OS 14.1%; p=0.02). Multivariable analysis showed that, for isolated brain, lung and liver metastases lung SRCC patients, palliative radiotherapy was associated with longer OS compared with observation. However, treatment of radiation couldn’t improve OS for lung SRCC patients with isolated bone metastases. For primary lung SRCC patients with isolated brain, liver or lung metastases, our analysis showed OS benefit of palliative radiation. Palliative radiotherapy should be recommended for metastatic lung SRCC in clinical management.

Primary signet‐ring cell carcinoma of the lung: A report of seven cases

Primary lung signet-ring cell carcinoma: a national analysis

Clinical Correlates and Prognostic Value of Different Metastatic Sites in Gastric and Colorectal Signet Ring Cell Carcinoma

Palliative Radiation Therapy For Metastatic Primary Signet Ring Cell Carcinoma Of The Lung: A Seer Analysis

Aberrant Expression of SCARA5 in Lung Adenocarcinoma and its Clinical Significance

The Characteristics and Prognostic Factors in Colorectal Cancer Containing Signet Ring Cell

Gastrointestinal Signet Ring Cell Malignancy: Current Advancement and Future Prospects

Primary signet-ring cell carcinoma of the urinary bladder ‒ A rare bladder tumor

Clinicopathological Characteristics and Survival Outcomes of Primary Signet Ring Cell Carcinoma of the Prostate: A SEER-Based Study

The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients.

Clinicopathological Characteristics And Survival Outcomes Of Primary Signet Ring Cell Carcinoma In The Stomach: Retrospective Analysis Of Single Center Database

Clinicopathological Characteristics and Prognosis of Resectable Lung Adenosquamous Carcinoma: a Population-Based Study of the SEER Database

Primary signet ring cell carcinoma of the cervix: A case report with review of the literature

Prognostic prediction and treatment options for gastric signet ring cell carcinoma: a SEER database analysis

Clinicopathological Characteristics and Survival Outcomes in Adenosquamous Carcinoma of the Lung: a Population-Based Study from the SEER Database.

Two cases report of secretory carcinoma of the salivary gland in the lung: one primary and one metastatic after many years

Treatment Options for Signet Ring Cell Carcinoma of the Urinary Bladder: A Population-Based Study

Primary Salivary Gland–Type Lung Cancer: Clinicopathological Analysis of 88 Cases from China

[Advances in the research of gastric signet ring cell carcinoma]

The Characteristics And Prognostic Effect Of E-Cadherin Expression In Colorectal Signet Ring Cell Carcinoma

Molecular characteristics of patients with colorectal signet-ring cell carcinoma with different ABO blood groups